James Bauersmith

James Bauersmith

Director/Board Member at LANNETT COMPANY, INC.
Health Technology
Consumer Services
Health Services

Profile

James Bauersmith is currently the Director at Lannett Co., Inc. and the Vice President & Translational Sciences at UPMC Enterprises.
Previously, he worked as the Director at Akorn, Inc., the SVP & Head of Global Drug Portfolio Strategy at Fresenius SE & Co. KGaA, the Chief Strategy Officer & General Counsel at ByHeart, Inc., and the SVP Head of Corporate Development & Procurement at Amneal Pharmaceuticals, Inc. Mr. Bauersmith received his undergraduate degree from the University of Notre Dame in 1998 and his graduate degrees from Drexel University in 2005 and The Pennsylvania State University in 2001.

James Bauersmith active positions

CompaniesPositionStart
LANNETT COMPANY, INC. Director/Board Member -
Corporate Officer/Principal 01/08/2021

Former positions of James Bauersmith

CompaniesPositionEnd
General Counsel 01/10/2021
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2019
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 31/05/2018
AKORN, INC. Director/Board Member -
See the detail of James Bauersmith's experience

Training of James Bauersmith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Non-Durables

Health Technology

  1. Stock Market
  2. Insiders
  3. James Bauersmith
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!